Cumberland Advisors’s Allergan plc AGN Stock Holding History

Cumberland Advisors’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,880	Closed	-$1.49M	–	81
2019 Q3	$1.49M	Sell	8,880 -475	-5%	-$77.4K	0.42%	37
2019 Q2	$1.57M	Sell	9,355 -700	-7%	-$96.9K	0.53%	35
2019 Q1	$1.47M	Buy	10,055 +1,000	+11%	+$145K	0.51%	35
2018 Q4	$1.21M	Buy	+9,055	New	+$1.48M	0.43%	32

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Cumberland Advisors's AGN Position: Q4 2019 in Review

Cumberland Advisors sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 8,880 shares — an estimated $1.49M sold.

Cumberland Advisors first reported a position in AGN in Q4 2018 and held it in 4 quarters. The position peaked at $1.57M in Q2 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

Cumberland Advisors reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
Cumberland Advisors sold 8,880 Allergan plc shares in Q4 2019, an estimated $1.49M.
Cumberland Advisors first reported a position in Allergan plc in Q4 2018 and held it in 4 quarters.
Cumberland Advisors's Allergan plc position peaked at $1.57M in Q2 2019.
957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Cumberland Advisors's 13F filing for Q4 2019, filed 16 Jan 2020.